Conference Coverage

Psoriatic arthritis treatment: “We’re not doing so well”


 

EXPERT ANALYSIS FROM RWCS 2018

Pages

Recommended Reading

Get ready for certolizumab for psoriasis
Psoriatic Arthritis ICYMI
ACR sounds more welcoming tone in new biosimilars position paper
Psoriatic Arthritis ICYMI
Here comes bimekizumab, the newest IL-17 inhibitor
Psoriatic Arthritis ICYMI
Risankizumab outpaced ustekinumab for complete clearance of plaque psoriasis
Psoriatic Arthritis ICYMI
Experts review the year in rheumatology ... and what lies ahead
Psoriatic Arthritis ICYMI
Biologics have best chance of achieving PASI 90 in psoriasis
Psoriatic Arthritis ICYMI
Ustekinumab quells aortic inflammation in patients with severe psoriasis
Psoriatic Arthritis ICYMI
Could guselkumab be a disease-modifying agent in plaque psoriasis?
Psoriatic Arthritis ICYMI
VIDEO: PPACMAN aims to advance the combined rheum-derm clinic approach in the community
Psoriatic Arthritis ICYMI
Do Psoriasis Patients Engage In Vigorous Physical Activity?
Psoriatic Arthritis ICYMI